Metabolomics

Dataset Information

0

A polyamine-centric blood-based metabolite panel predictive of poor response to CAR T-cell therapy in large B cell lymphoma


ABSTRACT:

Anti-CD19 chimeric antigen receptor (CAR) T-cell therapy for relapsed or refractory (r/r) large B-cell lymphoma (LBCL) results in durable response in only a subset of patients. MYC overexpression in LBCL tumors is associated with poor response to treatment. We tested whether a MYC-driven polyamine signature, as a liquid biopsy, is predictive of response to anti-CD19 CAR-T therapy in patients with r/r LBCL. Elevated plasma acetylated polyamines were associated with non-durable response. Concordantly, increased expression of spermidine synthase, a key enzyme which regulates levels of acetylated spermidine, was prognostic for survival in r/r LBCL. A broad metabolite screen identified additional markers which resulted in a 6-marker panel (6MetP) consisting of acetylspermidine, diacetylspermidine and lysophospholipids which was validated in an independent set from another institution as predictive of non-durable response to CAR T therapy. A polyamine centric metabolomics liquid biopsy panel has predictive value for response to CAR-T therapy in r/r LBCL.

INSTRUMENT(S): Liquid Chromatography MS - negative - reverse phase, Liquid Chromatography MS - positive - hilic, Liquid Chromatography MS - positive - reverse phase, Liquid Chromatography MS - negative - hilic

SUBMITTER: Yining Cai 

PROVIDER: MTBLS5381 | MetaboLights | 2022-10-31

REPOSITORIES: MetaboLights

Similar Datasets

2011-04-16 | E-GEOD-28650 | biostudies-arrayexpress
2019-06-10 | PXD013373 | Pride
2011-04-30 | E-GEOD-22759 | biostudies-arrayexpress
2012-09-11 | E-GEOD-36664 | biostudies-arrayexpress
2011-04-30 | GSE22759 | GEO
2021-08-09 | GSE171392 | GEO
2011-04-16 | GSE28650 | GEO
2010-05-14 | E-GEOD-13781 | biostudies-arrayexpress
2022-01-01 | GSE174041 | GEO
2022-01-01 | GSE176329 | GEO